BridgeMD
Tests treatment safety and results for Trigger Finger
Official title Effectiveness of Conservative Interventions in the Treatment of Trigger Finger
ClinicalTrials.gov ID: NCT06296017
What this study is testing
- What it's testing
- There is no study in the literature comparing the effectiveness of ESWT and splint therapy, which are the most commonly used approaches in the treatment of Trigger Finger (TF). The aim in this study is to investigate the effectiveness of ESWT and splint therapy used in the treatment of TF.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 65
You may be able to join if
- Volunteering
- Being between the ages of 18-65
- Being diagnosed with stage 1 or stage 2 (according to the Froimson classification) trigger finger
- Having the language and cognitive skills to answer the questionnaires used in the evaluation
You likely can't join if
- Being pregnant
- Having an inflammatory disorder
- Having had surgery on the hand/wrist
- Having a neurological disease
- NSAIDs, painkillers, etc. being on medication
- De Quervain's tenosynovitis, carpal tunnel syndrome
The study team makes the final eligibility decision.
Where it's taking place
- Ankara, Ankara, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Ankara, Ankara, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.